InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Browse the full record of transactions filed by Javitt Daniel C., Dirigeant. Insider active across 1 companies, notably NRX Pharmaceuticals, Inc.. Cumulatively, 9 disclosures have been recorded. Total volume traded: €5.7m. The latest transaction was disclosed on 3 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€159,149243,596 shares@ €0.6533100.0% of flow
Common Stock
SEC:0000880984-22-000007:0·
€5m100,000 shares@ €54.438899.0% of flow
Common Stock
SEC:0000921895-22-001872:0·
Ideal exit: 26 Feb 2023 (T+270)
€54,439100,000 shares@ €0.54441.0% of flow
Common Stock
SEC:0000921895-22-001874:0·
Ideal exit: 26 Feb 2023 (T+270)
434,594 shares
Common Stock
SEC:0000950142-21-003505:0·
434,594 shares
Common Stock
SEC:0000950142-21-003505·
13,971,864 shares
Common Stock
SEC:0000950142-21-001944·
46,332 shares
Common Stock
SEC:0000950142-21-001945·
13,971,864 shares
Common Stock
SEC:0000950142-21-001944:0·
46,332 shares
Common Stock
SEC:0000950142-21-001945:0·
9 of 9 declarations
About Javitt Daniel C.
Daniel C. Javitt is an executive at NRX Pharmaceuticals, Inc. Although he does not have a specified function, he contributes to the direction and strategy of the company. His role is essential in guiding strategic decisions and ensuring NRX Pharmaceuticals' performance.
